The presence of mature LAMP3+ DCs within lymphoid follicles has been associated with improved prognosis in non-small cell lung cancer (NSCLC)12, but the effect of tumour CCR7+ DCs on prognosis in human cancers more broadly has not been examined. Here, LAMP3 is linked to neoplasm.